New grad roles at Parabilis Medicines
Parabilis Medicines is a public, clinical-stage biopharmaceutical company developing Helicon peptide medicines for historically undruggable protein targets. Its pipeline focuses on oncology and other serious diseases, including the lead investigational medicine zolucatetide.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 51–200 employees
- Stage
- Series D
- Open roles
- 11
No current roles
Clear a filter to see every role.
Get new Parabilis Medicines new grad roles by email
Free account. Get new Parabilis Medicines new grad roles by email or push the minute they post.
